Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R T Dorr

Showing results (91-100 of 156) with videos related to

Pageof 16
Sort By:
Cancer Research|November 15, 1988
Direct relation of DNA lesions in multidrug-resistant human myeloma cells to intracellular doxorubicin concentrationW T Bellamy, R T Dorr, W S Dalton, et al.
Investigational New Drugs|January 1, 1995
Preclinical pharmacokinetics and antitumor activity of imexonR T Dorr, J D Liddil, M K Klein, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1986
Mitomycin C skin toxicity studies in mice: reduced ulceration and altered pharmacokinetics with topical dimethyl sulfoxideR T Dorr, M J Soble, J D Liddil, et al.
Cancer Treatment Reviews|September 1, 1980
Phase II trial of vindesine in breast cancer, lymphoma and other tumors: future directionsT P Miller, S E Jones, A B Chester, et al.
Journal of Medicinal Chemistry|March 19, 1993
2-substituted 1,2-dihydro-3H-dibenz[de,h]isoquinoline-1,3-diones. A new class of antitumor agentS M Sami, R T Dorr, D S Alberts, et al.
Biochemical Pharmacology|October 1, 1987
Mitomycin C resistant L1210 leukemia cells: association with pleiotropic drug resistanceR T Dorr, J D Liddil, J M Trent, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 28, 1998
Identification and characterization of in vitro metabolites of 2-[2'-(dimethylamino)ethyl]-1,2-dihydro-3H-dibenz [de,h]isoquinoline-1,3-dione (Azonafide)C A Mayr, S M Sami, W A Remers, et al.
Cancer Chemotherapy and Pharmacology|March 11, 1999
Pharmacokinetics of the green tea derivative, EGCG, by the topical route of administration in mouse and human skinK Dvorakova, R T Dorr, S Valcic, et al.
Journal of Chromatography. B, Biomedical Sciences and Applications|April 25, 2001
Pharmacokinetic analysis by high-performance liquid chromatography of intravenous nordihydroguaiaretic acid in the mouseJ D Lambert, R O Meyers, B N Timmermann, et al.
Cancer Research|August 1, 1985
Interactions of mitomycin C with mammalian DNA detected by alkaline elutionR T Dorr, G T Bowden, D S Alberts, et al.
Pageof 16

Showing results (91-100 of 156) with videos related to

Sort By:
Pageof 16
Cancer Research|November 15, 1988
Direct relation of DNA lesions in multidrug-resistant human myeloma cells to intracellular doxorubicin concentrationW T Bellamy, R T Dorr, W S Dalton, et al.
Investigational New Drugs|January 1, 1995
Preclinical pharmacokinetics and antitumor activity of imexonR T Dorr, J D Liddil, M K Klein, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1986
Mitomycin C skin toxicity studies in mice: reduced ulceration and altered pharmacokinetics with topical dimethyl sulfoxideR T Dorr, M J Soble, J D Liddil, et al.
Cancer Treatment Reviews|September 1, 1980
Phase II trial of vindesine in breast cancer, lymphoma and other tumors: future directionsT P Miller, S E Jones, A B Chester, et al.
Journal of Medicinal Chemistry|March 19, 1993
2-substituted 1,2-dihydro-3H-dibenz[de,h]isoquinoline-1,3-diones. A new class of antitumor agentS M Sami, R T Dorr, D S Alberts, et al.
Biochemical Pharmacology|October 1, 1987
Mitomycin C resistant L1210 leukemia cells: association with pleiotropic drug resistanceR T Dorr, J D Liddil, J M Trent, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 28, 1998
Identification and characterization of in vitro metabolites of 2-[2'-(dimethylamino)ethyl]-1,2-dihydro-3H-dibenz [de,h]isoquinoline-1,3-dione (Azonafide)C A Mayr, S M Sami, W A Remers, et al.
Cancer Chemotherapy and Pharmacology|March 11, 1999
Pharmacokinetics of the green tea derivative, EGCG, by the topical route of administration in mouse and human skinK Dvorakova, R T Dorr, S Valcic, et al.
Journal of Chromatography. B, Biomedical Sciences and Applications|April 25, 2001
Pharmacokinetic analysis by high-performance liquid chromatography of intravenous nordihydroguaiaretic acid in the mouseJ D Lambert, R O Meyers, B N Timmermann, et al.
Cancer Research|August 1, 1985
Interactions of mitomycin C with mammalian DNA detected by alkaline elutionR T Dorr, G T Bowden, D S Alberts, et al.
Pageof 16